Blood filtering therapy shows promise for MS in small trial
NCT ID NCT05168384
First seen Apr 11, 2026 · Last updated May 08, 2026 · Updated 4 times
Summary
This study tested a treatment called extracorporeal photopheresis (ECP) in 15 people with multiple sclerosis (MS). ECP involves taking blood, treating it with light and a drug, then returning it to the body. The goal was to see if it is safe and might help improve walking, hand function, and overall disability. The trial included both relapsing-remitting and secondary progressive MS patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abu Dhabi Stem Cells Center
Abu Dhabi, Abu Dhabi Emirate, 4600, United Arab Emirates
Conditions
Explore the condition pages connected to this study.